Navigation Links
ViroPharma Announces Publication of Cinryze™ (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine
Date:8/5/2010

t period.  All acute angioedema attacks during the study were eligible for rescue treatment with open-label Cinryze.  

The primary efficacy endpoint for each subject and for each treatment period was the number of attacks of angioedema that occurred during each period, normalized to 12 weeks.  Secondary end points, reported for each period, included average severity of attacks, average duration of attacks, the number of open-label injections of Cinryze, and the total number of days of swelling.  In addition, safety and changes from baseline in antigenic and functional levels of C1 inhibitor were evaluated.  

Twenty-four patients were enrolled in the prophylaxis trial and randomized to one of two groups, 12 to placebo and 12 to Cinryze in the first of two 12 week periods. Twenty-two of 24 subjects (11 from each randomized group) completed the first treatment period and then crossed over to the second period, and were included in the end point analyses. Although included in the analysis, 2 of these 22 analyzed subjects (one from each group) failed to complete the second 12 week period.  

The average normalized attack rates for all 22 subjects during the two 12-week crossover periods were 6.26 and 12.73 for the Cinryze and placebo treatments, respectively. The estimated average difference in attack rates between Cinryze and placebo was 6.47 (95% CI 4.21 to 8.73; p<0.001). The mean score for the severity of attacks was significantly lower during Cinryze prophylaxis than during placebo (1.3 +/- 0.85 versus 1.9 +/- 0.36, p=0.001). The total duration of attacks was also shorter with Cinryze prophylaxis compared to placebo (2.1 +/- 1.13 versus 3.4 +/- 1.39 days, p=0.002).  The number of subjects requiring open-label rescue therapy was less with Cinryze prophylaxis (11 versus 22), as was the total number of open-label injections (4.7 +/-
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Physician E-sampling is becoming well established across ... key marketing sales tactic in recent years. However, some ... a supplement to traditional sampling. According ... E-sampling has been seeded across multiple therapeutic areas- including ... has been in place for five or more years ...
(Date:9/4/2015)...  Janssen Research & Development, LLC (Janssen) announced ... has accepted for Priority Review the Biologics License ... patients with multiple myeloma who are refractory to ... agent (IMiD), or who have received three or ... and an IMiD. This is referred to as ...
(Date:9/4/2015)... -- Fair Rate Funding, a lawsuit funding firm located in ... increase in lawsuit filings in connection with the blood thinning ... Philadelphia Court of Common Pleas has ... Louisiana multi---district litigation (MDL), located in ... Louisiana , the filings are also on the ...
Breaking Medicine Technology:Current and Future Trends in Physician E-Sampling Programs for the Pharmaceutical Industry 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 3U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 4U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 5U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 6U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 7Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 2Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 3
(Date:9/4/2015)... ... 2015 , ... Inmar announced today that its regulatory experts ... Quality and Manufacturers, Dietary Supplements and Supply Chain Committees. , With the complex ... industry, it can be difficult for companies to navigate, stay abreast of all ...
(Date:9/4/2015)... ... ... “Getting away from the daily stressors and distractions of life may be ... says Jean Claude Wietzel, general manager at Four Seasons Resort Maui at Wailea. ... Five Star resort and Travel + Leisure’s No. 1 Hotel in Hawaii, has announced ...
(Date:9/4/2015)... Portland, ME (PRWEB) , ... September 04, 2015 ... ... Symposium focus on: the microbiome taking place in Hollywood, Florida October 9-10, 2015 ... ihsymposium.com/focus-event. , Speakers at the 2015 symposium are doctors and researchers at the ...
(Date:9/4/2015)... ... September 04, 2015 , ... Compliance ... to settlements under the Stark physician self-referral law. “Stark Law DOs and ... from Atlantic Information Services, Inc. (AIS), will detail which deals are attracting the ...
(Date:9/3/2015)... ... September 04, 2015 , ... AlignLife of Wauwatosa is excited to ... so many children and adults who don't have the ability to buy a jacket ... holding our annual Coat Drive to help those in need." , This is AlignLife's ...
Breaking Medicine News(10 mins):Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:AlignLife is Helping to Keep the Community Warm This Winter 2
... a recognized leader in providing turnkey electronic billing ... announced today that it has signed an agreement ... Corporation, to provide electronic clearinghouse services for Aon ... will enable Aon eSolutions, clients and medical providers ...
... highlights new hospitalist HIDI(TM) process at the 2009 ... ExecutivesSEATTLE, March 23 Hospital executives find themselves ... percent of America,s hospitals now operating at a ... Hospital leaders seek to control costs while maintaining ...
... Adds Advanced Drug Safety and Risk Management Applications to Extend ... News Facts , , ... that it has agreed to acquire Relsys International, Inc. ("Relsys"), ... with advanced analytics for the health sciences industry. , ...
... Volumes Seen in Houston Physician-Owned Hospitals, According ... 23 HealthLeaders-InterStudy, a leading provider of ... Texas laws favoring physicians have traditionally enabled ... directly with health systems, these regulations may ...
... (Nasdaq: WBMD ), the leading provider of ... a long-term strategic relationship with Boots UK Limited, the ... Kingdom, to jointly develop a consumer health and wellness ... will leverage WebMD,s online consumer health assets and expertise ...
... 23 Dr. Kevin Polk, a clinical psychologist with ... offering a new web program and DVD for stress ... Training (ACT). It emphasizes decreasing struggling with stress and ... traditional stress management techniques such as deep breathing and ...
Cached Medicine News:Health News:WorkCompEDI Announces Agreement with Aon eSolutions for Electronic Billing Services 2Health News:Sound Inpatient Physicians Report on New Clinical Processes to Reduce Healthcare Costs and Enhance Care 2Health News:Oracle Buys Relsys 2Health News:Oracle Buys Relsys 3Health News:In Texas, Favorable Regulations for Physicians May Backfire in Light of Market Downturn 2Health News:WebMD Announces Strategic Relationship with Boots UK to Launch New Consumer Health Portal in UK 2Health News:WebMD Announces Strategic Relationship with Boots UK to Launch New Consumer Health Portal in UK 3Health News:Surfing Your Stress to Success Program Offers a New Way of Dealing with Stress 2
... ENDOPATH EZ45 Endoscopic Linear Cutter has application ... surgical procedures for transection, resection, and/or creation ... staple line or tissue buttressing materials such ... reloaded seven times for a total of ...
... Linear Cutters provide a 45mm staple and ... the device suitable for many minimally invasive ... transection, resection, and/or creation of anastomoses in ... ,The LONG45A Endocutter has a shaft ...
ACUCLIP Endoscopic Right-Angle Multiple Clip Applier, 10 mm Shaft Diameter with 20, 8 mm Titanium Clips...
Insert only, Pilling-Weck medium clip size...
Medicine Products: